British pharmaceutical company GlaxoSmithKline is seeking regulatory approval for an antimalarial vaccine. The vaccine is being evaluated by the European Medicines Agencies in collaboration with the World Health Organization (WHO). This could prompt a major global health breakthrough as the disease affects 225 million people worldwide and results in the deaths of approximately 800,000 people, Read More…
In this article, Christopher Cowan examines the suitability of the F-35 for the RCAF’s needs and explores other possible options.
Gabriel Mallows reports on the recent decision of the French government to suspend the sale of French warships to the Russian Navy
In the second in a series of three, Daniel Woodburn examines the Trident nuclear missile facet of the Scottish independence debate.
Are targeted killings an effective method of counter terrorism?
Kyle Chatterson examines the impact of the recent Ebola outbreak on western nations, and how the search for treatments is progression.
Gabriel Mallows sheds light on the development of India’s nuclear submarine fleet
Is the F-35 the right fighter jet for Canada? A comparison of the Lockheed Martin F-35 Lightening II and the Boeing F/A-18 Super Hornet.
Piotr Zulauf examines how the advent of 3D printing may have dangerous consequences.
Gabriel Mallows weighs in on Brazil’s efforts to upgrade its armed forces as its global footprint deepens.